SHIELD JA - Strategies for Health Interventions to Eliminate Infection related Cancer

• titolo: Joint action on cancers caused by infections, vaccine-preventable cancers and addressing communicable diseases (HIV/AIDS, TB, Hepatitis);
• Referente: Angelo Pezzullo;
• Titolo breve: JA SHIELD;
• Bando: EU4H-2024-JA-IBA-03;
• Project Code: PRJ-1335;
• Data inizio: 01/11/2025; Data fine: 31/10/2028;
• Coordinatore: University of Copenhagen; Ente finanziatore: UNIONE EUROPEA;
• Link: https://chip.dk/research-areas/public-health/studies-and-projects/shield-ja/

Il principale obiettivo della Joint Action “Strategies for Health Interventions to Eliminate Infection related Cancer” (SHIELD) è ridurre la morbosità e la mortalità premature causate da malattie trasmissibili, in particolare dai tumori associati a infezioni e da quelli prevenibili tramite vaccinazione. La combinazione di diverse strategie in un programma di prevenzione completo ed efficace richiede il coordinamento tra molteplici e diversi stakeholder, tra cui la società civile, le autorità e le istituzioni di sanità pubblica, le strutture di supporto sociale, i sistemi sanitari e la comunità scientifica. Un aspetto centrale sarà l’identificazione e il superamento delle possibili barriere, sia strutturali sia individuali, che ostacolano l’efficacia dei programmi, nonché l’individuazione, lo sviluppo, il trasferimento e l’implementazione di pratiche promettenti. SHIELD mira a definire un programma efficace a livello europeo, combinando competenze complementari già attive in questo ambito. Il progetto risponde alle priorità del bando analizzando come garantire l’implementazione su larga scala di tutte le misure preventive rilevanti nei diversi Paesi e individuando le barriere che ne ostacolano l’attuazione, sia a livello strutturale sia individuale, con particolare attenzione al ruolo dello stigma e della discriminazione, soprattutto in relazione all’HIV ma anche ad altre infezioni. Attraverso l’applicazione di modelli analitici, SHIELD intende inoltre determinare la combinazione ottimale di misure preventive da adottare nei diversi Paesi e contesti. L’approccio parte dalla considerazione integrata di tutte le strategie di prevenzione – primaria, secondaria e terziaria – piuttosto che dal solo focus sulla copertura vaccinale, al fine di massimizzare l’impatto delle opzioni disponibili nella riduzione dei tumori causati da infezioni.

Dettagli contatto coordinatore progetto:
CHIP, Rigshospitalet, Denmark
Email: shield.rigshospitalet@regionh.dk

Funding statement

“Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HaDEA. Neither the European Union nor the granting authority can be held responsible for them.”

Consorzio SHIELD
Il consorzio SHIELD comprende:

1. Denmark - Capital Region of Denmark (RH/CHIP) Affiliated entities: RH/CHIP will engage with 4 AEs The Region of Southern Denmark (RSYD), Statens Serum Institut (SSI) & Central Denmark Region, Aarhus University Hospital AUH) and Sundhedsstyrelsen (SST)
2. Belgium - Sciensano (SCI) Affiliated entities: Sciensano will engage with 2 AEs University on Antwerp (UA)  and Vlaanderen – Department Zorg (BE-Dep. Zorg VL)
3. Bosnia and Herzegovina - PHI University Clinical Center of Republika Srpska (UKC RS)
4. Croatia - Croatian Institute of Public Health (CIPH)Affiliated entities: HZJZ will engage with 3 AEs Teaching Institute of Public Health of Split and Dalmatian County (TIPH SDC), Andrija Stampar Teaching Institute of Public Health (ASTIPH), Public Health Institute od Dubrovnik-Neretva County (PHi Dubrovnik) 
5. Cyprus - Department of Medical and Public Health Services of the Ministry of Health Cyprus (MPHS) Affiliated entities: MPHS will engage with 1 AE Cyprus University of Technology (CUT)
6. Czechia - The National institute of Public Health (SZÚ)
7. Estonia - National Institute for Health Development (TAI) Affiliated entities: TAI will engage with 2 AEs Estonian Health Board (EHB) and University of Tartu (UniTartu)
8. France – INSERM (INSERM)
9. France - Ministère de la Santé et de l'accès aux soins (DGS)
10. Finnish Institute of Health and Welfare (THL)
11. Germany - Federal Institute of Public Health (BIÖG)
12. Germany – Robert Koch Institute (RKI)
13. Greece - Ethnikos Organismos Dimosias Ygeias (National Public Health Organisation, EODY) Affiliated entities: EODY will engage with 1 AE National and Kapodistrian University of Athens (NKUA)
14. Hungary - National Directorate General for Hospitals (NDGH/OKFO) Affiliated entities: NDGH/OKFO will engage with 1 AE National Center for Public Health and Pharmacy (NNGYK)
15. Italy – Istituto Superiore di Sanità (ISS) Affiliated entities: ISS will engage with 12 AEs Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo (UNIPA), Università degli Studi di Padova – Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche (UNIPD), University of Cassino and Southern Lazio (UNICLAM), IRCCS Azienda Ospedaliero-Universitaria di Bologna (IRCCS AOUBO), University of Naples Federico II, Department of Clinical Medicine and Surgery (UNINA), Sapienza - University of Rome, Department of Public Health and Infectious Diseases (UNIROMA1),   Regione Liguria (Reg Lig), University of Pisa (UNIPI), Università Cattolica del Sacro Cuore (UCSC), Azienda Unita Sanitaria Locale Di Reggio Emilia (AUSL RE), Istituto per lo studio, la prevenzione e la rete oncologica (ISPRO), Regione Lombardia (Reg Lom)
16. Latvia - Riga Stradins University (RSU)
17. Lithuania – Ministry of health of the Republic of Lithuania (SAM LT) Affiliated entities: SAM LT will engage with 1 AE National Public Health Center (NVSC)
18. Lithuania - Vilnius University Faculty of Medicine (VU)
19. Malta – Ministry for Health and Active agening (MHA)
20. Moldova – National Agency for Public Health (NAPH)
21. Netherlands - Amsterdam Universitair Medisch Centrum (AUMC)
22. Norway - Norwegian Institute of Public Health (NIPH)
23. Poland - National Institute of Public Health NIH - National Research Institute (NIPH NIH – NRI)
24. Romania – National Institute of Public Health (NIPH)
25. Spain Institut Català d’Oncologia (ICO) Affiliated entities: ICO will engage with 2 AEs Universitat de Barcelona (UB), Secretariat for Public Health/Public Health Agency of Catalonia (GENCAT)
26. Spain - Dirección General de Salud Pública y Equidad en Salud del Ministerio de Sanidad de España (DGSPyES) Affiliated entities: DGSPyES will engage with 1 AE Fundación CSAI (FCSAI)
27. Sweden - Folkhälsomyndigheten / Public Health Agency of Sweden (PHAS) Affiliated entities: PHAS will engage with 4 AE Socialstyrelsen/The National Board of Health and Welfare (SoS), Karolinska Instituttet (KI), Region Stockholm/Karolinska University Hospital (Reg Sto), Region Uppsala / Uppsala Akademiska Sjukhus (REG UPS)
28. Ukraine - Public Health Center of the Ministry of Health of Ukraine (PHC)
29. Ukraine - National Cancer institute of the Ministry of Health of Ukraine (NCI)
30. Bosnia and Herzegovina - Institute for Public Health of the Federation of Bosnia and Herzegovina (PHI-FBIH)
31. Portugal – Directorate_General of Health (DGS) Affiliated entities: DGS will engage with 2 AEs Instituto de Saúde Pública da Universidade do Porto (ISPUP) and Unidade Local de Saúde de Santo António (ULSSA)

Associated Partners: 

• Italy- University of Florence (UniFi)
• Bosnia and Herzegovina – The Ministry of Health and Social Welfare of Republika Srpska (MoH SRPSKA)